癌症特异性表观基因组识别了核因子I家族蛋白质对脑髓母细胞瘤进展的致癌劫持
Ryo Shiraishi1, Gabriele Cancila2, Kohei Kumegawa3
1Department of Biochemistry and Cellular Biology, National Center of Neurology and Psychiatry (NCNP), Tokyo 187-8502, Japan.
Developmental cell
|June 4, 2024
概括
表观基因组重编程驱动癌症的发展. 这项研究确定了核因子I (NFIB) 作为脑髓母细胞瘤中的关键瘤调节剂,证明了非突变表观遗传变化如何导致脑瘤形成.
科学领域:
- 癌症生物学 癌症生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 发展生物学 发展生物学
背景情况:
- 正常的细胞发育依赖于基因表达的精确表观遗传调节.
- 非突变的表观遗传重编程被认为是癌症的标志,但在瘤发生过程中的具体变化尚未完全理解.
研究的目的:
- 为了研究发生在脑髓母细胞瘤中从正常细胞转变为恶性细胞期间的表观基因组变化.
- 确定参与胚胎脑瘤非突变表观遗传重编程的关键调节因素.
主要方法:
- 在小鼠模型中,对不同发育阶段的转变细胞进行比较表观基因组分析.
- 涉及表观遗传变化的转录因子的识别和功能验证.
- 已识别的转录因子的遗传和药理抑制.
主要成果:
- 确定了核因子I (NFIB) 转录因子家族作为癌前和癌细胞中的致癌调节剂.
- 证明NFIB在中枢细胞瘤中破坏癌症表观基因组方面发挥着至关重要的作用.
- 展示了NFIB抑制对破坏髓母细胞瘤表观基因组的影响.
结论:
- 由NFIB等发育转录因子驱动的表观基因组变化,通过非突变机制促进瘤发生.
- 这项研究提供了对脑髓母细胞瘤表观遗传情景的见解,并突出了NFIB作为潜在的治疗点.
- 了解这些非突变表观遗传驱动因素对于开发新型癌症疗法至关重要.
相关概念视频
Induced Pluripotent Stem Cells
4.0K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.0K
Epigenetic Regulation
3.0K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.0K
Cancer-Critical Genes I: Proto-oncogenes
8.8K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.8K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.4K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.4K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Methods of Nuclear Reprogramming
1.8K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.8K


